Literature DB >> 23456479

Differential effects of mesenchymal stem cells on a heterogeneous cell population within lung cancer cell lines.

Dan Luo1, Xiuping Yan, Dengqun Liu, Xiangdong Zhou, Guoxiang Liu.   

Abstract

Although mesenchymal stem cells (MSCs) promote lung cancer growth in vivo, in vitro studies indicate that they inhibit the proliferation of lung cancer cells. Because malignant tumors contain a heterogeneous cell population with variable capacity for self-renewal, the aim of this study was to determine whether the inconsistencies between in vitro and in vivo studies are a result of differential effects of MSCs on the heterogeneous cell population within lung cancer cell lines. Human MSCs were isolated from the bone marrow, and their cell surface antigen expression and multi-lineage differentiation capacity was examined at passage 10. CD133+ cells were isolated from A549 and H446 cell lines using immunomagnetic separation. The effects of MSCs on the growth and microsphere formation of heterogeneous cell populations within two lung cancer cell lines (A549 and H446) were compared. MSCs inhibited the in vitro proliferation of both cell lines, but significantly accelerated tumor formation and stimulated tumor growth in vivo (P < 0.05). In CD133+ cells isolated from both A549 and H446 cells, co-culture with MSCs for 1-3 days significantly increased their proliferation (P < 0.05). MSCs also significantly increased microsphere formation in both cell lines (P < 0.05). Selective stimulation of CD133+ cell growth may account for the discrepant effects of MSCs on lung cancer progression.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23456479     DOI: 10.1007/s11010-013-1600-3

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  35 in total

1.  The recruitment of exogenous endothelial progenitor cells in lung tumor model of nude mice.

Authors:  Qiang Peng; Ming Liu; Shu-Min Song; Xian-Hua Li; Yi-Hua Du; Yong Zhi; Min-Yong Wang
Journal:  Chin J Cancer       Date:  2010-11

Review 2.  Brain tumour stem cells.

Authors:  Angelo L Vescovi; Rossella Galli; Brent A Reynolds
Journal:  Nat Rev Cancer       Date:  2006-06       Impact factor: 60.716

3.  Human mesenchymal stem cells play a dual role on tumor cell growth in vitro and in vivo.

Authors:  Lin Li Hui Tian; Weiming Yue; Feng Zhu; Shuhai Li; Wenjun Li
Journal:  J Cell Physiol       Date:  2011-07       Impact factor: 6.384

4.  Elimination of human lung cancer stem cells through targeting of the stem cell factor-c-kit autocrine signaling loop.

Authors:  Vera Levina; Adele Marrangoni; Tingting Wang; Simul Parikh; Yunyun Su; Ronald Herberman; Anna Lokshin; Elieser Gorelik
Journal:  Cancer Res       Date:  2009-12-22       Impact factor: 12.701

5.  Human mesenchymal stem cells inhibit metastasis of a hepatocellular carcinoma model using the MHCC97-H cell line.

Authors:  Guo-Cai Li; Qing-Hai Ye; Yu-Hua Xue; Hai-Jing Sun; Hai-Jun Zhou; Ning Ren; Hu-Liang Jia; Jiong Shi; Jin-Cai Wu; Chun Dai; Qiong-Zhu Dong; Lun-Xiu Qin
Journal:  Cancer Sci       Date:  2010-10-07       Impact factor: 6.716

6.  Human mesenchymal stem cells inhibit cancer cell proliferation by secreting DKK-1.

Authors:  Y Zhu; Z Sun; Q Han; L Liao; J Wang; C Bian; J Li; X Yan; Y Liu; C Shao; R C Zhao
Journal:  Leukemia       Date:  2009-01-15       Impact factor: 11.528

7.  Human mesenchymal stem cells induce E-cadherin degradation in breast carcinoma spheroids by activating ADAM10.

Authors:  Angela Dittmer; Kristina Hohlfeld; Jana Lützkendorf; Lutz P Müller; Jürgen Dittmer
Journal:  Cell Mol Life Sci       Date:  2009-07-15       Impact factor: 9.261

8.  Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors.

Authors:  Matus Studeny; Frank C Marini; Richard E Champlin; Claudia Zompetta; Isaiah J Fidler; Michael Andreeff
Journal:  Cancer Res       Date:  2002-07-01       Impact factor: 12.701

9.  Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma.

Authors:  Aarif Y Khakoo; Shibani Pati; Stasia A Anderson; William Reid; Mohamed F Elshal; Ilsa I Rovira; Ahn T Nguyen; Daniela Malide; Christian A Combs; Gentzon Hall; Jianhu Zhang; Mark Raffeld; Terry B Rogers; William Stetler-Stevenson; Joseph A Frank; Marvin Reitz; Toren Finkel
Journal:  J Exp Med       Date:  2006-04-24       Impact factor: 14.307

10.  Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation.

Authors:  Carmen Chak-Lui Wong; Daniele M Gilkes; Huafeng Zhang; Jasper Chen; Hong Wei; Pallavi Chaturvedi; Stephanie I Fraley; Chun-Ming Wong; Ui-Soon Khoo; Irene Oi-Lin Ng; Denis Wirtz; Gregg L Semenza
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-12       Impact factor: 11.205

View more
  3 in total

1.  Effect of human Wharton's jelly mesenchymal stem cell secretome on proliferation, apoptosis and drug resistance of lung cancer cells.

Authors:  F Hendijani; Sh Haghjooy Javanmard; L Rafiee; H Sadeghi-Aliabadi
Journal:  Res Pharm Sci       Date:  2015 Mar-Apr

2.  Recapitulating epithelial tumor microenvironment in vitro using three dimensional tri-culture of human epithelial, endothelial, and mesenchymal cells.

Authors:  Surya P Lamichhane; Neha Arya; Esther Kohler; Shengnan Xiang; Jon Christensen; V Prasad Shastri
Journal:  BMC Cancer       Date:  2016-08-02       Impact factor: 4.430

3.  Bone marrow stem cells therapy alleviates vascular injury in a chronic obstructive pulmonary disease‑obstructive sleep apnea overlap syndrome rat model.

Authors:  Hong Bi; Jian He; Xu He; Junyi Du; Min Chen; Zhaoming Huang; Chao Yang; Lijuan Yang; Hang Li; Kaihua Zhou; Qing Wang; Lewei He; Zhixian Jin
Journal:  Mol Med Rep       Date:  2020-11-25       Impact factor: 2.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.